
Acutaas Chemicals Board Approves AGM, Director Re-appointments, ESOPs, ₹212 Cr Capex
Acutaas Chemicals Ltd announced key decisions from its Board of Directors meeting held on August 22, 2026. The board approved the notice for the 19th Annual General Meeting (AGM) scheduled for September 24, 2026, and adopted the Annual Report for FY 2025-26. Significant approvals include the re-appointment of Mr. Ram Mohan Lokhande as Whole Time Director and Mrs. Anita Bandyopadhyay as Non-Executive Independent Director, both for five-year terms starting February 8, 2027. The company also approved extending its ESOP 2023 scheme to eligible employees of its Indian subsidiaries. Furthermore, a substantial capital expenditure plan of up to ₹212 crores was sanctioned for establishing a new manufacturing plant in Gujarat for electronic grade chemicals, to be undertaken by the company or its subsidiaries.
Key Highlights
- Board approved 19th AGM notice for September 24, 2026.
- Re-appointment of two directors approved for five-year terms.
- ESOP benefits to be extended to subsidiary employees.
- Capital expenditure of ₹212 crores approved for new plant.
- Annual Report for FY 2025-26 adopted.
Price Impact
More from ACUTAAS